Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 39 of 39 entries
View as:

A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults

Phase: N/A Priority: Normal
NCT ID: NCT06475846 Org: User:
Start: 06/25/24 End: 10/29/24 Due: 10/29/25

Efficacy and Safety of HRS9531 Tablet in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06841445 Org: User:
Start: 04/07/25 End: 12/31/25 Due: 12/31/26

A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06649344 Org: User:
Start: 10/31/24 End: 09/30/26 Due: 09/30/27

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05516966 Org: User:
Start: 10/12/22 End: 05/24/23 Due: 05/24/24

The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution

Phase: N/A Priority: Normal
NCT ID: NCT06792955 Org: User:
Start: 02/11/25 End: 06/06/25 Due: 06/06/26

Mass Balance Study of [14C]HRS9531 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06855147 Org: User:
Start: 03/31/25 End: 06/30/25 Due: 06/30/26

A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea

Phase: N/A Priority: Normal
NCT ID: NCT06565871 Org: User:
Start: 08/31/24 End: 12/31/25 Due: 12/31/26

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06994650 Org: User:
Start: 06/30/25 End: 01/31/27 Due: 01/31/28

HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT06391710 Org: User:
Start: 05/06/24 End: 01/31/26 Due: 01/31/27

Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06654960 Org: User:
Start: 11/05/24 End: 12/26/24 Due: 12/26/25

A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition

Phase: N/A Priority: Normal
NCT ID: NCT05788588 Org: User:
Start: 04/28/23 End: 12/31/23 Due: 12/31/24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS3797 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05701826 Org: User:
Start: 02/15/23 End: 06/02/23 Due: 06/02/24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06762600 Org: User:
Start: 01/16/25 End: 12/31/25 Due: 12/31/26

Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT05808374 Org: User:
Start: 04/30/23 End: 05/31/24 Due: 05/31/25